Evolent Health, Inc. (EVH) Upgraded to Buy at Citigroup

Market Context

Evolent Health, Inc. operates in the Healthcare sector. The stock currently trades at $4.27 with a market capitalization of $453.4M.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Citigroup's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Evolent Health, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 11, 2026	Citigroup	Buy	N/A
Aug 10, 2026	Canaccord Genuity	Buy	N/A
Jul 28, 2026	TD Cowen	Buy	N/A
Jul 23, 2026	Citigroup	Neutral	N/A
Jul 21, 2026	Canaccord Genuity	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View EVH Stock Page